235 related articles for article (PubMed ID: 17417934)
1. Economic and clinical impact of innovative pharmacy benefit designs in the management of diabetes pharmacotherapy.
Berger J
Am J Manag Care; 2007 Apr; 13 Suppl 2():S55-8. PubMed ID: 17417934
[TBL] [Abstract][Full Text] [Related]
2. Reducing patient drug acquisition costs can lower diabetes health claims.
Mahoney JJ
Am J Manag Care; 2005 Aug; 11(5 Suppl):S170-6. PubMed ID: 16111439
[TBL] [Abstract][Full Text] [Related]
3. Prescription drug benefits: Rx for cost management--commentary.
Carlsen MA
Benefits Q; 1993; 9(3):81-8. PubMed ID: 10127207
[No Abstract] [Full Text] [Related]
4. Prescription drug benefits in a managed care plan: balancing quality and costs.
Heenan J
Med Interface; 1994 Jan; 7(1):84-6, 88, 91-2. PubMed ID: 10131628
[TBL] [Abstract][Full Text] [Related]
5. Need for integrated data in pharmacy benefits.
Martens G; Clor GE
J Health Care Benefits; 1993; 3(1):57-60. PubMed ID: 10130352
[No Abstract] [Full Text] [Related]
6. Effective strategies for managing pharmacy benefits.
Jacobson D
Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
[TBL] [Abstract][Full Text] [Related]
7. The evolving pharmacy benefit market.
Navarro RP
Med Interface; 1994 May; 7(5):65-7, 70. PubMed ID: 10134345
[TBL] [Abstract][Full Text] [Related]
8. Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses.
Rodbard HW; Green AJ; Fox KM; Grandy S;
Diabetes Res Clin Pract; 2010 Mar; 87(3):360-5. PubMed ID: 20047768
[TBL] [Abstract][Full Text] [Related]
9. Choices in prescription-drug benefit programs: mail versus community pharmacy services.
Kirking DM; Ascione FJ; Richards JW
Milbank Q; 1990; 68(1):29-51. PubMed ID: 2215427
[TBL] [Abstract][Full Text] [Related]
10. Effects of benefit design change across 5 disease states.
Brixner DI; Joish VN; Odera GM; Avey SG; Hanson DM; Cannon HE
Am J Manag Care; 2007 Jun; 13(6 Pt 2):370-6. PubMed ID: 17567238
[TBL] [Abstract][Full Text] [Related]
11. A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures.
Piette JD; Heisler M; Horne R; Caleb Alexander G
Soc Sci Med; 2006 Feb; 62(4):846-57. PubMed ID: 16095789
[TBL] [Abstract][Full Text] [Related]
12. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost.
Fendrick AM; Smith DG; Chernew ME; Shah SN
Am J Manag Care; 2001 Sep; 7(9):861-7. PubMed ID: 11570020
[TBL] [Abstract][Full Text] [Related]
13. Shifting gears.
Tweed V
Bus Health; 1994 May; 12(5):28-9, 32, 34 passim. PubMed ID: 10134334
[No Abstract] [Full Text] [Related]
14. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study.
Tseng CW; Tierney EF; Gerzoff RB; Dudley RA; Waitzfelder B; Ackermann RT; Karter AJ; Piette J; Crosson JC; Ngo-Metzger Q; Chung R; Mangione CM
Diabetes Care; 2008 Feb; 31(2):261-6. PubMed ID: 18000177
[TBL] [Abstract][Full Text] [Related]
15. New standard for pharmacy benefits.
Walgran CC
J Health Care Benefits; 1994; 3(3):60-4. PubMed ID: 10131221
[No Abstract] [Full Text] [Related]
16. Economics of diabetes mellitus.
Krein SL; Funnell MM; Piette JD
Nurs Clin North Am; 2006 Dec; 41(4):499-511, v-vi. PubMed ID: 17059971
[TBL] [Abstract][Full Text] [Related]
17. A new frontier for prescription drug services.
Frankel RB
J Health Care Benefits; 1994; 3(6):24-30. PubMed ID: 10135306
[TBL] [Abstract][Full Text] [Related]
18. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
19. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus.
Rubin RR
Am J Med; 2005 May; 118 Suppl 5A():27S-34S. PubMed ID: 15850551
[TBL] [Abstract][Full Text] [Related]
20. Long-term consequences of type 2 diabetes mellitus: economic impact on society and managed care.
Killilea T
Am J Manag Care; 2002 Oct; 8(16 Suppl):S441-9. PubMed ID: 12408407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
